The FLT1 gene helps the body control how new blood vessels grow by making a receptor for vascular growth signals. This matters in the placenta and in tissues that need a steady blood supply. If it does not work as expected, blood vessel signaling can become unbalanced, which may contribute to abnormal vessel growth or pregnancy complications such as preeclampsia. In medicine, this gene is important because it helps regulate blood vessel and placental health, but it is better known in research than in popular culture.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do the work. Others mainly help decide when and where certain processes happen, and how strongly they occur. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
FLT1Gene function
What if the gene works
The FLT1 gene helps cells respond to signals that guide blood vessel growth. It plays a key role in forming the placenta and fine tuning how new blood vessels develop throughout the body.
Risk
What if the gene does not work
Milder to more severe variants in the FLT1 gene can weaken how cells fine tune blood vessel growth signals. Cells may then respond less accurately to vascular growth cues, disrupting normal control of vessel formation.
Treatment
What does that mean for your treatment
No FLT1-specific treatment or drug choice is currently established for people with pathogenic variants in the FLT1 gene. The FLT1 gene is being studied as a biomarker and treatment target in conditions involving abnormal blood vessel growth, including some cancers and preeclampsia.
Conditions associated with FLT1
Gene function
What if the gene works
Blood vessels need clear, balanced signals so tissues can get oxygen and nutrients. In your body, the FLT1 gene supports processes that shape and fine tune blood vessel growth and the signals that guide vessel cells. This helps explain how the FLT1 gene helps control blood vessel growth during development and in day to day tissue upkeep.
The FLT1 gene makes a receptor that sits on the surface of certain cells, especially cells lining blood vessels. This receptor detects VEGF family signals (messages that guide blood vessel growth) and passes that information into the cell.
By binding these growth messages, the FLT1 protein helps fine tune how strongly vessel cells respond. This keeps blood vessel formation more controlled as tissues grow, heal, and adapt.
The FLT1 gene helps guide where new blood vessels branch and how they organize into a useful network. This supports steady delivery of oxygen and nutrients to developing tissues and to tissues that are renewing themselves.
Your cells can also make a shorter FLT1 form that is released outside the cell. It can catch VEGF family signals before they reach other receptors, helping keep signaling in balance.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the FLT1 gene can alter how variants influence the FLT1 gene's function by changing receptor shape, stability, or the balance between the membrane bound receptor and the soluble FLT1 form. Some variants may mildly reduce signaling or lower the amount of receptor made, while more disruptive variants can sharply weaken ligand binding, disrupt signal transfer, or shift splicing toward extra soluble FLT1. At the cell level, this can change how strongly blood vessel growth signals are captured and passed on.
How variants are linked to conditions
The FLT1 gene does not yet have a broadly confirmed link to a specific inherited health condition, although research on how FLT1 gene variants are linked to health conditions is still developing. If you have a confirmed FLT1-related finding on genetic testing, your doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. Still, in some situations, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to FLT1 itself. Because FLT1 has mostly been linked to risk patterns rather than a single predictable condition, personal risk usually also depends on many other genes, health factors, and life circumstances.
Inheritance of FLT1 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of the FLT1 gene variants tied to one specific FLT1 related condition. Research links FLT1 to pregnancy related traits such as preeclampsia risk, but these findings do not support a single clear cut dominant or recessive pattern. For families asking about the inheritance of the FLT1 gene variants, this usually means the result is interpreted as a risk influence rather than a predictable inherited diagnosis. The FLT1 gene is located on chromosome 13, which is an autosome, so you inherit one copy from each parent.
What does my FLT1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific condition for FLT1 that clearly predicts what a result means for relatives. If you have a specific FLT1 finding and want to know whether family members could share it or whether it matters for family planning, a doctor or genetic counselor can explain it in the context of your exact result.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the FLT1 gene, genetic testing uses a blood sample, saliva, or cheek swab to read your DNA. This kind of genetic testing for FLT1 variants may be done as part of a multigene panel or broader sequencing test, and results can show whether a variant was found, not found, or needs more study.
When should I consider getting a genetic test?
There is not yet a broadly established FLT1-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health and family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to a drug in different ways. These differences are common and are one reason medication response is not always the same from person to person. In some cases, genetics can help explain why someone is more sensitive to a medicine or why a treatment has a weaker effect.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medications. By looking at links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. With many medicines, genes influence both how powerfully a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore the topic further, more information is available in the LearnHub.
Drugs influenced by the FLT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine use, so general questions about symptoms, side effects, or treatment choices are best discussed with your doctor. Research on the FLT1 gene has looked at whether it may influence response to some cancer medicines that target blood vessel growth, but this is not part of routine prescribing.
History
First described in the scientific literature as part of early genetics, the FLT1 gene came into focus in the early 1990s as researchers mapped genes involved in blood vessel growth. Building on this early work, scientists identified its link to a receptor later called VEGFR1, which became important in cancer and eye disease research. In recent decades, awareness of this gene’s role has grown through studies of pregnancy complications, especially preeclampsia. A major step came when researchers found that a circulating form related to the FLT1 gene could be measured in blood and used to improve research and clinical assessment. Over time, scientists’ understanding of the gene’s medical relevance has broadened from basic vessel biology to pregnancy medicine and targeted therapy research.